Literature DB >> 18054317

Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.

Makoto Miyazaki1, Matthew T Flowers, Harini Sampath, Kiki Chu, Carolin Otzelberger, Xueqing Liu, James M Ntambi.   

Abstract

Stearoyl-CoA desaturase-1 (SCD1), a critical regulator of energy metabolism, catalyzes the synthesis of monounsaturated fats. To understand the tissue-specific role of SCD1 in energy homeostasis, we used Cre-lox technology to generate mice with a liver-specific knockout of Scd1 (LKO). LKO mice were protected from high-carbohydrate, but not high-fat (HF), diet-induced adiposity and hepatic steatosis. Additionally, on a high-sucrose, very low-fat (HSVLF) diet, lipogenesis and levels of nuclear SREBP-1 and ChREBP were significantly decreased in the livers of LKO relative to Scd1(lox/lox) (Lox) mice. HSVLF feeding in LKO mice caused hypoglycemia and hepatic carbohydrate reduction due to an impairment of gluconeogenesis. Oleate, but not stearate, supplementation normalized adiposity, gluconeogenesis, triglyceride secretion, and hepatic lipogenesis of LKO mice. These results indicate that hepatic SCD1 expression (and thus, oleate) is required for carbohydrate-induced adiposity, but SCD1 inhibition in extrahepatic tissues is required to protect mice from HF-induced obesity and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054317     DOI: 10.1016/j.cmet.2007.10.014

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  161 in total

1.  Combined deletion of SCD1 from adipose tissue and liver does not protect mice from obesity.

Authors:  Matthew T Flowers; Lacmbouh Ade; Maggie S Strable; James M Ntambi
Journal:  J Lipid Res       Date:  2012-06-05       Impact factor: 5.922

2.  Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Authors:  Vanessa Fritz; Zohra Benfodda; Geneviève Rodier; Corinne Henriquet; François Iborra; Christophe Avancès; Yves Allory; Alexandre de la Taille; Stéphane Culine; Hubert Blancou; Jean Paul Cristol; Françoise Michel; Claude Sardet; Lluis Fajas
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

Review 3.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

4.  Identification of differentially expressed genes between hepatocytes of Landes geese (Anser anser) and Sichuan White geese (Anser cygnoides).

Authors:  Zhixiong Pan; Jiwen Wang; Chunchun Han; Ningfeng Zhai; Jia Lv; Zehui Zhou; Hui Tang; Shuxia Xiang; Jing Wang; Liang Li
Journal:  Mol Biol Rep       Date:  2010-03-18       Impact factor: 2.316

5.  Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.

Authors:  Tuoyu Geng; Lili Xia; Sarah Russo; Davida Kamara; Lauren Ashley Cowart
Journal:  Nutr Res       Date:  2015-07-02       Impact factor: 3.315

6.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.

Authors:  Donald B Jump; Moises Torres-Gonzalez; L Karl Olson
Journal:  Biochem Pharmacol       Date:  2010-12-22       Impact factor: 5.858

7.  Increased lipid synthesis and decreased β-oxidation in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model of metabolic syndrome.

Authors:  Shizuyo Tanaka; Tohru Yamazaki; Satoshi Asano; Atsushi Mitsumoto; Daisuke Kobayashi; Naomi Kudo; Yoichi Kawashima
Journal:  Lipids       Date:  2013-09-18       Impact factor: 1.880

Review 8.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

9.  Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.

Authors:  Richard G Lee; Wuxia Fu; Mark J Graham; Adam E Mullick; Donna Sipe; Danielle Gattis; Thomas A Bell; Sheri Booten; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

10.  Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis.

Authors:  Harvey K Chiu; Kun Qian; Kayoko Ogimoto; Gregory J Morton; Brent E Wisse; Nalini Agrawal; Thomas O McDonald; Michael W Schwartz; Helén L Dichek
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.